Loading term…
Adverse event reports submitted directly by healthcare professionals or patients to regulatory authorities, bypassing the pharmaceutical company.
A patient reports an adverse reaction directly to FDA via MedWatch Form 3500. The FDA may forward this report to the manufacturer for additional information.
EU Pharmacovigilance Legislation, FDA MedWatch
Not having processes to receive and reconcile reports forwarded from regulatory authorities.
How do you handle reports received from regulatory authorities that were originally submitted by HCPs or patients directly?